DELFI: STAT+: Delfi Diagnostics announces key data, study design for its liquid biopsy test
Delfi Diagnostics has announced key data and the clinical trial design for its liquid biopsy test to help screen for lung cancer.
Read full article »
Delfi is a Maryland-based biotechnology company that research and develops fluid biopsy tests for the early detection of cancer.
Read more